Evaluation of Heterozygosity Loss in STR-Loci of Tumor DNA in Multiple Myeloma Patients with Plasmacytoma Based on the Molecular Analysis of Complex Archival Tumor Samples
Elena Nikulina, Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), А. М. Ковригина(Shupyk National Healthcare University of Ukraine), Andrey Sudarikov(National Medical Research Center for Hematology), Т. Н. Обухова(Ministry of Health of the Russian Federation), Tatiana Abramova(Ministry of Health of the Russian Federation), M. V. Solovev(Ministry of Health of the Russian Federation), Yana Kozhevnikova(Lomonosov Moscow State University), М. В. Фирсова(Ministry of Health of the Russian Federation), Natalya Risinskaya(National Medical Research Center for Hematology)
Cited by 1
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
|Blood|2020|132
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59